SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-19-000026
Filing Date
2019-04-23
Accepted
2019-04-23 08:23:53
Documents
5
Effectiveness Date
2019-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce04232019defa14a.htm DEFA14A 19879
2 jounce2019notice01.jpg GRAPHIC 349216
3 jounce2019notice02.jpg GRAPHIC 490583
4 jounce2019notice03.jpg GRAPHIC 197568
5 jounce2019notice04.jpg GRAPHIC 146577
  Complete submission text file 0001640455-19-000026.txt   1650155
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 19760690
SIC: 2836 Biological Products, (No Diagnostic Substances)